These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 11304725

  • 1. Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
    Björk T, Schalken J, Wittjes W, Ljungberg B, Lilja H.
    Prostate; 2001 Apr; 47(1):14-20. PubMed ID: 11304725
    [Abstract] [Full Text] [Related]

  • 2. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F, Kwiatkowski MK, Piironen T, Pettersson K, Lümmen G, Wernli M, Wiefelspütz J, Graber SF, Goepel M, Huber A, Tscholl R.
    Cancer; 1998 Dec 15; 83(12):2540-7. PubMed ID: 9874461
    [Abstract] [Full Text] [Related]

  • 3. Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
    Becker C, Piironen T, Pettersson K, Björk T, Wojno KJ, Oesterling JE, Lilja H.
    J Urol; 2000 Jan 15; 163(1):311-6. PubMed ID: 10604382
    [Abstract] [Full Text] [Related]

  • 4. Free/Total PSA (F/T ratio) kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomy.
    Gregorakis AK, Malovrouvas D, Stefanakis S, Petraki K, Scorilas A.
    Clin Chim Acta; 2005 Jul 24; 357(2):196-201. PubMed ID: 15936010
    [Abstract] [Full Text] [Related]

  • 5. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
    Shariat SF, Gottenger E, Nguyen C, Song W, Kattan MW, Andenoro J, Wheeler TM, Spencer DM, Slawin KM.
    Cancer Res; 2002 Oct 15; 62(20):5974-9. PubMed ID: 12384565
    [Abstract] [Full Text] [Related]

  • 6. Rapid elimination by glomerular filtration of free prostate specific antigen and human kallikrein 2 after renal transplantation.
    Bruun L, Ekberg H, Bjørk T, Lilja H, Høglund P, Christensson A.
    J Urol; 2004 Apr 15; 171(4):1432-5. PubMed ID: 15017191
    [Abstract] [Full Text] [Related]

  • 7. hK2 and free PSA, a prognostic combination in predicting minimal prostate cancer in screen-detected men within the PSA range 4-10 ng/ml.
    Raaijmakers R, de Vries SH, Blijenberg BG, Wildhagen MF, Postma R, Bangma CH, Darte C, Schröder FH.
    Eur Urol; 2007 Nov 15; 52(5):1358-64. PubMed ID: 17499425
    [Abstract] [Full Text] [Related]

  • 8. Measurement of prostate specific antigen complexed to alpha1-antichymotrypsin to avoid unnecessary biopsy in patients with serum prostate specific antigen levels 4-20 ng/mL.
    Nakano Y, Okamura K, Takamura S, Okamoto N, Narishima M, Yoshino Y, Hattori R, Ono Y, Ohshima S, Nagasaka T.
    Int J Urol; 2005 Aug 15; 12(8):721-7. PubMed ID: 16174045
    [Abstract] [Full Text] [Related]

  • 9. Clinical utility of human glandular kallikrein 2 within a neural network for prostate cancer detection.
    Stephan C, Jung K, Soosaipillai A, Yousef GM, Cammann H, Meyer H, Xu C, Diamandis EP.
    BJU Int; 2005 Sep 15; 96(4):521-7. PubMed ID: 16104903
    [Abstract] [Full Text] [Related]

  • 10. Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy.
    Lilja H, Haese A, Björk T, Friedrich MG, Piironen T, Pettersson K, Huland E, Huland H.
    J Urol; 1999 Dec 15; 162(6):2029-34; discussion 2034-5. PubMed ID: 10569562
    [Abstract] [Full Text] [Related]

  • 11. Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA.
    Scorilas A, Plebani M, Mazza S, Basso D, Soosaipillai AR, Katsaros N, Pagano F, Diamandis EP.
    Prostate; 2003 Feb 15; 54(3):220-9. PubMed ID: 12518327
    [Abstract] [Full Text] [Related]

  • 12. Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
    Steuber T, Niemela P, Haese A, Pettersson K, Erbersdobler A, Felix Chun KH, Graefen M, Kattan MW, Huland H, Lilja H.
    Prostate; 2005 Apr 01; 63(1):13-8. PubMed ID: 15378521
    [Abstract] [Full Text] [Related]

  • 13. Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
    Haese A, Vaisanen V, Lilja H, Kattan MW, Rittenhouse HG, Pettersson K, Chan DW, Huland H, Sokoll LJ, Partin AW.
    J Urol; 2005 Mar 01; 173(3):752-6. PubMed ID: 15711262
    [Abstract] [Full Text] [Related]

  • 14. Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer.
    Stephan C, Jung K, Nakamura T, Yousef GM, Kristiansen G, Diamandis EP.
    Int J Urol; 2006 Mar 01; 13(3):238-43. PubMed ID: 16643616
    [Abstract] [Full Text] [Related]

  • 15. Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer.
    Pannek J, Rittenhouse HG, Evans CL, Finlay JA, Bruzek DJ, Cox JL, Chan DW, Subong EN, Partin AW.
    Urology; 1997 Nov 01; 50(5):715-21. PubMed ID: 9372881
    [Abstract] [Full Text] [Related]

  • 16. The value of (-7, -5)pro-prostate-specific antigen and human kallikrein-2 as serum markers for grading prostate cancer.
    Bangma CH, Wildhagen MF, Yurdakul G, Schröder FH, Blijenberg BG.
    BJU Int; 2004 Apr 01; 93(6):720-4. PubMed ID: 15049979
    [Abstract] [Full Text] [Related]

  • 17. Free and total human glandular kallikrein 2 in patients with prostate cancer.
    Väisänen V, Pettersson K, Alanen K, Viitanen T, Nurmi M.
    Urology; 2006 Jul 01; 68(1):219-25. PubMed ID: 16844459
    [Abstract] [Full Text] [Related]

  • 18. Serum tPSA, cPSA, related density parameters and chromogranin A as predictors of positive margins after radical prostatectomy.
    Custovic Z, Kraus O, Tomaskovic I, Tarle M.
    Anticancer Res; 2007 Jul 01; 27(4C):2817-21. PubMed ID: 17695453
    [Abstract] [Full Text] [Related]

  • 19. Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.
    Shariat SF, Abdel-Aziz KF, Roehrborn CG, Lotan Y.
    Eur Urol; 2006 Feb 01; 49(2):293-302. PubMed ID: 16387412
    [Abstract] [Full Text] [Related]

  • 20. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
    Miller N, Smolkin ME, Bissonette E, Theodorescu D.
    Cancer; 2005 Jun 15; 103(12):2499-506. PubMed ID: 15852361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.